Florida HB 573: Educator Certification Pathways for Veterans
Status: Laid on Table; companion bill(s) passed, see CS/SB 896 (Ch. 2022-186) (as of 2022-03-03)
State: Florida · Session: 2022 · Bill: HB 573
Subjects: subject index
Sponsors: Education and Employment Committee, Secondary Education and Career Development Subcommittee, Snyder, Benjamin, Eskamani, Gregory, Killebrew, Learned, McClain, Morales, Rizo, Salzman
Bill Text
HB 573 2026 CODING: Words stricken are deletions; words underlined are additions. hb573-00 Page 1 of 3 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S A bill to be entitled 1 An act relating to discounted drug pricing study; 2 requiring the Agency for Health Care Administration to 3 conduct or contract for a specified study; providing 4 requirements for such study; requiring the agency to 5 provide the results to the Governor and the 6 Legislature by a specified date; providing an 7 effective date. 8 9 Be It Enacted by the Legislature of the State of Florida: 10 11 Section 1. (1) The Agency for Health Care Administration 12 shall conduct or contract for a detailed fiscal impact study to 13 determine the feasibility of implementing the following 14 provisions relating to discounted drug prices under the 340B 15 Drug Pricing Program: 16 (a)1. Requiring drug manufacturers to sell a drug to 17 Medicaid pharmacies at not more than the 340B Drug Pricing 18 Program discounted price if the drug is: 19 a. On the Medicaid preferred drug list as described in s. 20 409.912(5), Florida Statutes. 21 b. A covered drug under the 340B Drug Pricing Program. 22 2. Authorizing drug manufacturers to deliver drugs sold in 23 accordance with subparagraph 1. to the purchasing Medicaid 24 pharmacy by any method used by the drug manufacturer. 25 HB 573 2026 CODING: Words stricken are deletions; words underlined are additions. hb573-00 Page 2 of 3 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S 3. If a drug manufacturer sells a drug in accordance with 26 subparagraph 1. to a Medicaid pharmacy at the 340B Drug Pricing 27 Program discounted price and such discounted price is higher 28 than the state Medicaid negotiated price, requiring the drug 29 manufacturer to pay a rebate to the state equal to the 30 difference between the discounted price and the state Medicaid 31 negotiated price. 32 (b) Requiring pharmacy benefits managers participating in 33 the Medicaid program to pay a Medicaid pharmacy the 340B Drug 34 Pricing Program discounted price plus the professional 35 dispensing fee as determined under rule 59G-4.251, Florida 36 Administrative Code, as amended, for any drug that is on the 37 Medicaid preferred drug list as described in s. 409.912(5), 38 Florida Statutes, and that is a covered drug under the 340B Drug 39 Pricing Program. 40 (c)1. Requiring drug wholesalers and distributors to sell 41 a drug to a Medicaid pharmacy at the 340B Drug Pricing Program 42 discounted price if the drug is: 43 a. On the Medicaid preferred drug list as described in s. 44 409.912(5), Florida Statutes. 45 b. A covered drug under the 340B Drug Pricing Program. 46 2. Prohibiting drug wholesalers and distributors from 47 changing an existing pricing model or program that is in place 48 with a Medicaid pharmacy by exempting a drug described in 49 paragraph (a) from the pricing model or program or by 50 HB 573 2026 CODING: Words stricken are deletions; words underlined are additions. hb573-00 Page 3 of 3 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S referencing such drug in any way in the pricing model or 51 program. 52 (d) Requiring Medicaid pharmacies to provide a covered 53 drug under the 340B Drug Pricing Program at the discounted price 54 only to Medicaid recipients. 55 (2) The agency shall submit the results of the study to 56 the Governor, the President of the Senate, and the Speaker of 57 the House of Representatives, by January 31, 2027. 58 Section 2. This act shall take effect July 1, 2026. 59
View Florida HB 573 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.